Galimedix Therapeutics, Inc.
www.galimedix.comGalimedix Therapeutics is a Phase 2 neuropharmaceutical company developing novel first-in-class drugs with ground-breaking potential to slow or stop the progression of neurodegeneration and to improve function in glaucoma and dry AMD – leading causes of blindness – and also in Alzheimer’s disease.
Read more
Galimedix Therapeutics is a Phase 2 neuropharmaceutical company developing novel first-in-class drugs with ground-breaking potential to slow or stop the progression of neurodegeneration and to improve function in glaucoma and dry AMD – leading causes of blindness – and also in Alzheimer’s disease.
Read more
Country
State
Maryland
Industry
Employees
1-10
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Pharmacologist and Vice President of Non - Clinical Development
Email ****** @****.comPhone (***) ****-****Co - Founder and Chief Scientific Officer of Galimedix Therapeutics Inc.
Email ****** @****.comPhone (***) ****-****Co - Founder and Executive Chairman
Email ****** @****.comPhone (***) ****-****
Technologies
(12)
Reach decision makers at Galimedix Therapeutics, Inc.
Free credits every month!
Galimedix Therapeutics, Inc. FAQ
Pharmaceutical Manufacturing
